| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
23,078,700 | 21,594,100 | 20,644,800 | 17,376,300 | 13,024,201 |
| Cost of Revenue
|
-10,640,900 | -11,566,000 | -9,953,100 | -8,641,300 | -6,731,739 |
|
Gross Profit
|
12,437,800 | 10,028,100 | 10,691,700 | 8,735,000 | 6,292,462 |
| Selling, General and Administrative Expenses
|
-3,955,600 | -7,727,800 | -7,835,100 | -6,377,500 | -5,206,302 |
|
Operation and Maintenance Expenses
|
-729,600 | -729,600 | -582,500 | -581,500 | -554,589 |
|
Research and Development Expenses
|
-185,100 | -- | -185,100 | -251,400 | -263,939 |
| Depreciation, Amortization and Depletion
|
-1,232,700 | -1,251,200 | -1,245,600 | -1,231,600 | -1,134,437 |
|
Taxes Other Than Income Taxes
|
-49,700 | -49,700 | -38,700 | -42,100 | -65,299 |
| Other Income/Expense, Operating
|
-6,196,400 | 365,900 | 413,200 | -613,700 | -623,715 |
|
Operating Income/Expenses
|
-11,384,700 | -9,392,400 | -9,288,700 | -9,097,800 | -7,848,281 |
|
Total Operating Profit/Loss
|
1,053,100 | 635,700 | 1,403,000 | -362,800 | -1,555,819 |
| Total Net Finance Income/Expense
|
-316,700 | -262,900 | -181,800 | -219,900 | -167,963 |
| Net Investment Income
|
0 | 549,800 | 308,200 | 288,700 | 363,713 |
| Irregular Income/Expenses
|
2,049,000 | 1,982,300 | 9,500 | -559,800 | -407,009 |
|
Other Income/Expense, Non-Operating
|
718,500 | 7,900 | 7,000 | 4,200 | 3,449 |
|
Non-Operating Income/Expenses, Total
|
2,450,800 | 2,277,100 | 142,900 | -486,800 | -207,810 |
|
Pretax Income
|
3,503,900 | 2,923,800 | 1,545,900 | -849,600 | -1,763,629 |
| Provision for Income Tax
|
-456,100 | -395,400 | -170,700 | -88,000 | -258,647 |
|
Net Income from Continuing Operations
|
3,047,800 | 2,528,400 | 1,375,200 | -937,600 | -2,022,276 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
3,047,800 | 2,528,400 | 1,375,200 | -937,600 | -2,022,276 |
|
Net Income after Non-Controlling/Minority Interests
|
3,047,800 | 2,528,400 | 1,375,200 | -937,600 | -2,022,276 |
|
Net Income Available to Common Stockholders
|
3,047,800 | 2,528,400 | 1,375,200 | -937,600 | -2,022,276 |
|
Diluted Net Income Available to Common Stockholders
|
3,047,800 | 2,528,400 | 1,375,200 | -937,600 | -2,022,276 |
| Basic EPS
|
43.29 | 35.91 | 19.53 | -13.32 | -28.72 |
| Diluted EPS
|
43.22 | 35.85 | 19.47 | -13.32 | -28.72 |
|
Basic Weighted Average Shares Outstanding
|
70,440.50 | 70,405.75 | 70,405.75 | 70,405.75 | 70,413.51 |
|
Diluted Weighted Average Shares Outstanding
|
70,567.66 | 70,532.90 | 70,621.31 | 70,405.75 | 70,413.51 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
3,820,600 | 3,185,600 | 1,724,400 | -634,800 | -1,606,270 |
|
EBITDA
|
5,053,300 | 4,436,800 | 2,970,000 | 596,800 | -471,833 |
3/31/2023 - 7/1/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade